Mirum Pharmaceuticals, Inc.
DE ˙ DB ˙ US6047491013
77,12 € ↑0,96 (1,26%)
2026-06-05
DEL PRIS
SecurityDE:08D / Mirum Pharmaceuticals, Inc.
InstitutionVirtus ETF Advisers LLC
Latest Disclosed Ownership4,000 shares
Latest Disclosed Value $ 369,520
Virtus ETF Advisers LLC ownership in 08D / Mirum Pharmaceuticals, Inc.

On May 14, 2026 - Virtus ETF Advisers LLC filed a 13F-HR form disclosing ownership of 4,000 shares of Mirum Pharmaceuticals, Inc. (DE:08D) valued at $300,000 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 4,000 shares of Mirum Pharmaceuticals, Inc.. This represents a change in shares of 0.00% during the quarter. The current value of the position is $308,480 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F MIRUM PHARMACEUTICALS COM 604749101 4,000 0 0.00 370 17.14 0.1717
2026-02-13 2025-12-31 13F MIRUM PHARMACEUTICALS COM 604749101 4,000 0 0.00 316 7.51 0.1494
2026-02-13 2025-09-30 13F/A-1 MIRUM PHARMACEUTICALS COM 604749101 4,000 4,000 293 0.1615
2025-11-14 2025-09-30 13F MIRUM PHARMACEUTICALS COM 604749101 4,000 4,000 293 0.1182
2026-02-13 2025-03-31 13F/A-1 MIRUM PHARMACEUTICALS COM 604749101 0 -8,270 -100.00 0 -100.00
2025-05-14 2025-03-31 13F MIRUM PHARMACEUTICALS COM 604749101 0 -8,270 0
2025-02-14 2024-12-31 13F MIRUM PHARMACEUTICALS COM 604749101 8,270 -4,074 -33.00 342 -29.11 0.1396
2024-11-14 2024-09-30 13F MIRUM PHARMACEUTICALS COM 604749101 12,344 0 0.00 481 13.98 0.2251
2024-08-14 2024-06-30 13F MIRUM PHARMACEUTICALS COM 604749101 12,344 1,329 12.07 422 52.90 0.2067
2024-05-15 2024-03-31 13F MIRUM PHARMACEUTICALS COM 604749101 11,015 1,585 16.81 277 -0.72 0.1470
2024-02-15 2023-12-31 13F MIRUM PHARMACEUTICALS COM 604749101 9,430 -1,309 -12.19 278 -17.99 0.1767
2023-11-07 2023-09-30 13F MIRUM PHARMACEUTICALS COM 604749101 10,739 -1,390 -11.46 339 8.31 0.2061
2023-08-14 2023-06-30 13F MIRUM PHARMACEUTICALS COM 604749101 12,129 -4,960 -29.02 314 -23.66 0.1860
2023-05-15 2023-03-31 13F MIRUM PHARMACEUTICALS COM 604749101 17,089 299 1.78 410 25.38 0.2258
2023-02-14 2022-12-31 13F MIRUM PHARMACEUTICALS COM 604749101 16,790 4,472 36.30 327 26.25 0.1710
2022-11-14 2022-09-30 13F MIRUM PHARMACEUTICALS COM 604749101 12,318 181 1.49 259 9.75 0.1033
2022-08-12 2022-06-30 13F MIRUM PHARMACEUTICALS COM 604749101 12,137 976 8.74 236 -4.07 0.0875
2022-05-16 2022-03-31 13F MIRUM PHARMACEUTICALS COM 604749101 11,161 -656 -5.55 246 30.85 0.1101
2022-02-14 2021-12-31 13F MIRUM PHARMACEUTICALS COM 604749101 11,817 -167 -1.39 188 -21.34 0.0710
2021-11-15 2021-09-30 13F MIRUM PHARMACEUTICALS COM 604749101 11,984 -618 -4.90 239 9.63 0.1052
2021-08-10 2021-06-30 13F MIRUM PHARMACEUTICALS COM 604749101 12,602 87 0.70 218 -12.10 0.0896
2021-05-17 2021-03-31 13F MIRUM PHARMACEUTICALS COM 604749101 12,515 223 1.81 248 15.35 0.1047
2021-02-12 2020-12-31 13F MIRUM PHARMACEUTICALS COM 604749101 12,292 -5,166 -29.59 215 -36.01 0.0892
2020-11-13 2020-09-30 13F MIRUM PHARMACEUTICALS COM 604749101 17,458 -2,377 -11.98 336 -12.95 0.1762
2020-08-05 2020-06-30 13F MIRUM PHARMACEUTICALS COM 604749101 19,835 19,835 386 0.1828
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.